120 related articles for article (PubMed ID: 11867196)
1. Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis.
Clemente C; Elba S; Buongiorno G; Berloco P; Guerra V; Di Leo A
Cancer Lett; 2002 Apr; 178(2):123-9. PubMed ID: 11867196
[TBL] [Abstract][Full Text] [Related]
2. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
4. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
5. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ
Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326
[TBL] [Abstract][Full Text] [Related]
6. Albumin and prealbumin may predict retinol status in patients with liver cirrhosis.
Chang WT; Ker CG; Hung HC; Lee KT; Chen LS; Chiang HC; Huang MC
Hepatogastroenterology; 2008; 55(86-87):1681-5. PubMed ID: 19102369
[TBL] [Abstract][Full Text] [Related]
7. Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis.
Wang YY; Lin SY
Horm Res; 2003; 60(4):185-90. PubMed ID: 14530607
[TBL] [Abstract][Full Text] [Related]
8. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
[TBL] [Abstract][Full Text] [Related]
9. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
Sadik NA; Ahmed A; Ahmed S
Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
[TBL] [Abstract][Full Text] [Related]
10. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
11. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
Yagmur E; Rizk M; Stanzel S; Hellerbrand C; Lammert F; Trautwein C; Wasmuth HE; Gressner AM
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):755-61. PubMed ID: 17700260
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients?
Cipriani F; Fantini C; Ratti F; Lauro R; Tranchart H; Halls M; Scuderi V; Barkhatov L; Edwin B; Troisi RI; Dagher I; Reggiani P; Belli G; Aldrighetti L; Abu Hilal M
Surg Endosc; 2018 Feb; 32(2):617-626. PubMed ID: 28717870
[TBL] [Abstract][Full Text] [Related]
14. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.
Tanaka K; Sakai H; Hashizume M; Hirohata T
Cancer Res; 2000 Sep; 60(18):5106-10. PubMed ID: 11016636
[TBL] [Abstract][Full Text] [Related]
15. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
Huang CF; Yeh ML; Tsai PC; Hsieh MH; Yang HL; Hsieh MY; Yang JF; Lin ZY; Chen SC; Wang LY; Dai CY; Huang JF; Chuang WL; Yu ML
J Hepatol; 2014 Jul; 61(1):67-74. PubMed ID: 24613362
[TBL] [Abstract][Full Text] [Related]
16. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
17. Blood concentrations of thirteen vitamins in cirrhotic patients.
Kanematsu T; Kawano T; Sugimachi K
Nutrition; 1989; 5(3):179-82. PubMed ID: 2562452
[TBL] [Abstract][Full Text] [Related]
18. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis.
Yutani S; Tanaka M; Mutsumoto H; Imai N; Sata M; Shichijo S; Harada M; Itoh K
Jpn J Cancer Res; 2002 Apr; 93(4):453-8. PubMed ID: 11985796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
